Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 25.5B | 23.6B | 24.4B | 28.3B |
Cost of revenue | 22.5B | 21.3B | 21.7B | 23.6B |
Gross profit | 3.0B | 2.3B | 2.7B | 4.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.7B | 1.9B | 1.4B | 1.6B |
Other operating expenses | -22M | -80M | 41M | 85M |
Operating income | 1.3B | 482M | 1.2B | 3.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 1.5B | 580M | 1.3B | 3.1B |
Tax provision | 348M | 93M | 290M | 658M |
Net income | 1.1B | 487M | 1.0B | 2.4B |
Basic EPS | 1.1 | 0.5 | 1.1 | 2.4 |
Diluted EPS | 1.1 | 0.5 | 1.1 | 2.4 |
Basic average shares | 996.6M | 996.6M | 996.6M | 996.6M |
Diluted average shares | 996.6M | 996.6M | 996.6M | 996.6M |
EBITDA | 2.4B | 1.6B | 2.3B | 4.0B |
Net income from continuing op. | 1.4B | 487M | 1.2B | 3.0B |
Minority interests | -2M | -4M | 0 | 1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |